A high-performance liquid chromatography method with UV detection was developed and validated for the simultaneous quantification of linezolid (LZD), rifampicin (RFP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma. The method is based on a simple organic protein precipitation that guarantees rapid sample preparation and a direct injection into the high-performance liquid chromatography system. The use of quinoxaline as internal standard improved accuracy (relative standard deviation, RSD% <14.9%) and precision (RSD% <14.3%). The recovery was 75.9% (RSD% = 5.8). The limits of quantification were 0.234 microg/mL for LEVO, 0.312 microg/mL for LZD, 0.156 microg/mL for MOXI, and 0.622 microg/mL for RFP. This method allows the simultaneous measurement of LEVO, LZD, MOXI, and RFP in human plasma and may be used for both routine clinical applications and pharmacokinetic studies.

Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV

BAIETTO, LORENA
First
;
D'AVOLIO, ANTONIO;DE ROSA, Francesco Giuseppe;GARAZZINO, Silvia;SICCARDI, MARCO;SCIANDRA, Mauro;DI PERRI, Giovanni
Last
2009-01-01

Abstract

A high-performance liquid chromatography method with UV detection was developed and validated for the simultaneous quantification of linezolid (LZD), rifampicin (RFP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma. The method is based on a simple organic protein precipitation that guarantees rapid sample preparation and a direct injection into the high-performance liquid chromatography system. The use of quinoxaline as internal standard improved accuracy (relative standard deviation, RSD% <14.9%) and precision (RSD% <14.3%). The recovery was 75.9% (RSD% = 5.8). The limits of quantification were 0.234 microg/mL for LEVO, 0.312 microg/mL for LZD, 0.156 microg/mL for MOXI, and 0.622 microg/mL for RFP. This method allows the simultaneous measurement of LEVO, LZD, MOXI, and RFP in human plasma and may be used for both routine clinical applications and pharmacokinetic studies.
2009
31
1
104
109
Lorena Baietto; Antonio D'Avolio; Francesco Giuseppe De Rosa; Silvia Garazzino; Samantha Patanella; Marco Siccardi; Mauro Sciandra; Giovanni Di Perri...espandi
File in questo prodotto:
File Dimensione Formato  
TDM feb 2009.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 197.09 kB
Formato Adobe PDF
197.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Simultaneous Quantification of Linezolid, Rifampicin, Levofloxacin, and Moxifloxacin in Human Plasma Using High-Performance Liquid Chromatography With UV.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 197.09 kB
Formato Adobe PDF
197.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/62803
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 44
social impact